Norway· NO-ID_69D9D298-A1C2-45AB-9E75-DC358B33869D

Elidel

A pimecrolimus product containing pimecrolimus, registered in Norway by Viatris AS. The same ATC class is registered in 13 of our 19 countries.

ATC D11AH02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedElidelATCD11AH02REGISTER NO.NO-ID_69D9D298-A1C2-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Pimecrolimus is registered in 13 of 19 countries.

Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Pimecrolimus · ATC D11AH02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Pimecrolimus
Manufacturer
Viatris AS
Country
Norway (NO)
ATC code
D11AH02
ATC class
Pimecrolimus
Defined daily dose
20 mg, T
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_69D9D298-A1C2-45AB-9E75-DC358B33869D
  • no_varenummer
    187595
    30
    NOK 337.1
  • gtin
    7046261875950

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for pimecrolimus.

Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pimecrolimus · interactions on record

217 records

  • 9 moderate
  • 83 minor
  • 125 info

Most severe, free to view

  • FostamatinibB02BX09moderate
  • EchinaceaD03AH02moderate
  • TemsirolimusL01EG01moderate
  • SirolimusL01EG04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pimecrolimus in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pimecrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Elidel
  • Belgium · Elidel
  • Bulgaria · Елидел
  • Cyprus · Elidel
  • Czechia · Elidel
  • Germany · Elidel
  • Denmark · Elidel
  • Estonia · Elidel
  • Spain · Elidel
  • Finland · Elidel
  • United Kingdom (Northern Ireland) · Elidel
  • Greece · Elidel
  • Croatia · Elidel
  • Hungary · Elidel
  • Iceland · Elidel
  • Italy · Elidel
  • Lithuania · Elidel
  • Luxembourg · Elidel
  • Latvia · Elidel
  • Malta · Elidel
  • Netherlands · Elidel
  • Poland · Elidel
  • Portugal · Elidel
  • Romania · Elidel
  • Sweden · Elidel
  • Slovenia · Elidel
  • Slovakia · Elidel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4d7bb259-693c-4be0-90c4-126fcf1a4880
GET /v1/drugs/4d7bb259-693c-4be0-90c4-126fcf1a4880?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "fest",
  "status": "A",
  "atc_name": "Pimecrolimus",
  "merkevare_id": "ID_69D9D298-A1C2-45AB-9E75-DC358B33869D",
  "name_form_strength": "Elidel krem 10 mg/g",
  "prescription_group": "C"
}

See everything about pimecrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.